Augment effect of quetiapine in the treatment of depression with psychotic symptoms
HU Zheng-d
Abstract
HU Zheng-d
Abstract
Objective:To study the efficacy and safety of paroxetine combined with quetiapine for the treatment of depression with psychotic symptoms.Method:46 patients with psychotic depression were randomly assigned to two groups combined group,paroxetine combined with quetiapine,and control group,paroxetine only,for 6 weeks.Hamilton depression scale(HAMD),Wechsler memory scale revised edition(WMS-RC)and treatment emergent symptoms scale(TESS)were used to evaluate the clinical efficacy and safety.Results:The score of HAMD reduced significantly after every treatment time in two groups(P0.05-0.01),with markedly lower score of HAMD in combined group in 4 weeks and 6 weeks treatment when compared to that in control group(both P0.05).The scores of all the items in WMS-RC improved remarkably after the treatment(both P0.05),with short-term memory improved observably in combined group compared with that in control group(P0.05).There was no significant difference in adverse effects between the two groups.Conclusion:Paroxetine combined with quetiapine in the treatment of depression with psychotic symptoms may augment the treatment effect and has a better safety.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the efficacy and safety of paroxetine combined with quetiapine for the treatment of depression with psychotic symptoms.Method:46 patients with psychotic depression were randomly assigned to two groups combined group,paroxetine combined with quetiapine,and control group,paroxetine only,for 6 weeks.Hamilton depression scale(HAMD),Wechsler memory scale revised edition(WMS-RC)and treatment emergent symptoms scale(TESS)were used to evaluate the clinical efficacy and safety.Results:The score of HAMD reduced significantly after every treatment time in two groups(P0.05-0.01),with markedly lower score of HAMD in combined group in 4 weeks and 6 weeks treatment when compared to that in control group(both P0.05).The scores of all the items in WMS-RC improved remarkably after the treatment(both P0.05),with short-term memory improved observably in combined group compared with that in control group(P0.05).There was no significant difference in adverse effects between the two groups.Conclusion:Paroxetine combined with quetiapine in the treatment of depression with psychotic symptoms may augment the treatment effect and has a better safety.
Key concepts: Hamd, Paroxetine, Quetiapine, Hamilton depression scale, Depression (economics), Wechsler Adult Intelligence Scale, Psychology, Psychiatry